UniProt ID | IRS4_HUMAN | |
---|---|---|
UniProt AC | O14654 | |
Protein Name | Insulin receptor substrate 4 | |
Gene Name | IRS4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1257 | |
Subcellular Localization |
Cell membrane Peripheral membrane protein Cytoplasmic side . |
|
Protein Description | Acts as an interface between multiple growth factor receptors possessing tyrosine kinase activity, such as insulin receptor, IGF1R and FGFR1, and a complex network of intracellular signaling molecules containing SH2 domains. Involved in the IGF1R mitogenic signaling pathway. Promotes the AKT1 signaling pathway and BAD phosphorylation during insulin stimulation without activation of RPS6KB1 or the inhibition of apoptosis. Interaction with GRB2 enhances insulin-stimulated mitogen-activated protein kinase activity. May be involved in nonreceptor tyrosine kinase signaling in myoblasts. Plays a pivotal role in the proliferation/differentiation of hepatoblastoma cell through EPHB2 activation upon IGF1 stimulation. May play a role in the signal transduction in response to insulin and to a lesser extent in response to IL4 and GH on mitogenesis. Plays a role in growth, reproduction and glucose homeostasis. May act as negative regulators of the IGF1 signaling pathway by suppressing the function of IRS1 and IRS2.. | |
Protein Sequence | MASCSFTRDQATRRLRGAAAAAAAALAAVVTTPLLSSGTPTALIGTGSSCPGAMWLSTATGSRSDSESEEEDLPVGEEVCKRGYLRKQKHGHRRYFVLKLETADAPARLEYYENARKFRHSVRAAAAAAAAAASGAAIPPLIPPRRVITLYQCFSVSQRADARYRHLIALFTQDEYFAMVAENESEQESWYLLLSRLILESKRRRCGTLGAQPDGEPAALAAAAAAEPPFYKDVWQVIVKPRGLGHRKELSGVFRLCLTDEEVVFVRLNTEVASVVVQLLSIRRCGHSEQYFFLEVGRSTVIGPGELWMQVDDCVVAQNMHELFLEKMRALCADEYRARCRSYSISIGAHLLTLLSARRHLGLVPLEPGGWLRRSRFEQFCHLRAIGDGEDEMLFTRRFVTPSEPVAHSRRGRLHLPRGRRSRRAVSVPASFFRRLAPSPARPRHPAEAPNNGARLSSEVSGSGSGNFGEEGNPQGKEDQEGSGGDYMPMNNWGSGNGRGSGGGQGSNGQGSSSHSSGGNQCSGEGQGSRGGQGSNGQGSGGNQCSRDGQGTAGGHGSGGGQRPGGGHGSGGGQGPGDGHGSGGGKNSGGGKGSGSGKGSDGDGERGKSLKKRSYFGKLTQSKQQQMPPPPPPPPPPPPAGGTGGKGKSGGRFRLYFCVDRGATKECKEAKEVKDAEIPEGAARGPHRARAFDEDEDDPYVPMRPGVATPLVSSSDYMPMAPQNVSASKKRHSRSPFEDSRGYMMMFPRVSPPPAPSPPKAPDTNKEDDSKDNDSESDYMFMAPGAGAIPKNPRNPQGGSSSKSWSSYFSLPNPFRSSPLGQNDNSEYVPMLPGKFLGRGLDKEVSYNWDPKDAASKPSGEGSFSKPGDGGSPSKPSDHEPPKNKAKRPNRLSFITKGYKIKPKPQKPTHEQREADSSSDYVNMDFTKRESNTPAPSTQGLPDSWGIIAEPRQSAFSNYVNVEFGVPFPNPANDLSDLLRAIPRANPLSLDSARWPLPPLPLSATGSNAIEEEGDYIEVIFNSAMTPAMALADSAIRYDAETGRIYVVDPFSECCMDISLSPSRCSEPPPVARLLQEEEQERRRPQSRSQSFFAAARAAVSAFPTDSLERDLSPSSAPAVASAAEPTLALSQVVAAASALAAAPGIGAAAAAAGFDSASARWFQPVANAADAEAVRGAQDVAGGSNPGAHNPSANLARGDNQAGGAAAAAAAPEPPPRSRRVPRPPEREDSDNDDDTHVRMDFARRDNQFDSPKRGR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MASCSFTRDQATRR -CCCCCCCHHHHHHH | 19.62 | - | |
62 | Phosphorylation | WLSTATGSRSDSESE EECCCCCCCCCCCCC | 25.02 | 22210691 | |
64 | Phosphorylation | STATGSRSDSESEEE CCCCCCCCCCCCCCC | 47.38 | 22496350 | |
66 | Phosphorylation | ATGSRSDSESEEEDL CCCCCCCCCCCCCCC | 44.24 | 29666759 | |
68 | Phosphorylation | GSRSDSESEEEDLPV CCCCCCCCCCCCCCC | 55.02 | 22496350 | |
81 | Ubiquitination | PVGEEVCKRGYLRKQ CCCHHHHHHCCHHHC | 54.77 | 32015554 | |
99 | Ubiquitination | HRRYFVLKLETADAP CCEEEEEEEEECCCC | 38.69 | 32015554 | |
111 | Phosphorylation | DAPARLEYYENARKF CCCHHHHHHHHHHHH | 22.22 | 29978859 | |
112 | Phosphorylation | APARLEYYENARKFR CCHHHHHHHHHHHHH | 8.04 | 29978859 | |
202 | Ubiquitination | SRLILESKRRRCGTL HHHHHHHHHHHHCCC | 40.32 | - | |
208 | Phosphorylation | SKRRRCGTLGAQPDG HHHHHHCCCCCCCCC | 26.16 | 22496350 | |
240 | Neddylation | DVWQVIVKPRGLGHR HHHHHHCCCCCCCCH | 20.20 | 32015554 | |
240 | Ubiquitination | DVWQVIVKPRGLGHR HHHHHHCCCCCCCCH | 20.20 | 22817900 | |
248 | Ubiquitination | PRGLGHRKELSGVFR CCCCCCHHHHCCEEE | 58.28 | - | |
251 | Phosphorylation | LGHRKELSGVFRLCL CCCHHHHCCEEEEEC | 33.72 | 29666759 | |
291 | Phosphorylation | RCGHSEQYFFLEVGR HCCCCCEEEEEEECC | 7.70 | 30257219 | |
336 | Phosphorylation | RALCADEYRARCRSY HHHHHHHHHHHHHHC | 15.32 | 28509920 | |
342 | Phosphorylation | EYRARCRSYSISIGA HHHHHHHHCCCHHHH | 27.19 | 26552605 | |
343 | Phosphorylation | YRARCRSYSISIGAH HHHHHHHCCCHHHHH | 7.23 | 26552605 | |
344 | Phosphorylation | RARCRSYSISIGAHL HHHHHHCCCHHHHHH | 15.88 | 26552605 | |
346 | Phosphorylation | RCRSYSISIGAHLLT HHHHCCCHHHHHHHH | 14.72 | 26552605 | |
353 | Phosphorylation | SIGAHLLTLLSARRH HHHHHHHHHHHHHHH | 31.82 | 26552605 | |
356 | Phosphorylation | AHLLTLLSARRHLGL HHHHHHHHHHHHHCC | 23.89 | 24719451 | |
375 | Phosphorylation | PGGWLRRSRFEQFCH CCCCCHHHHHHHHEE | 34.58 | 22496350 | |
384 | Methylation | FEQFCHLRAIGDGED HHHHEEEEEECCCCC | 10.65 | 115480607 | |
398 | Methylation | DEMLFTRRFVTPSEP CCEEEEEEECCCCCC | 27.59 | 115480583 | |
401 | Phosphorylation | LFTRRFVTPSEPVAH EEEEEECCCCCCCCC | 20.56 | 22496350 | |
403 | Phosphorylation | TRRFVTPSEPVAHSR EEEECCCCCCCCCCC | 45.20 | 22496350 | |
409 | Phosphorylation | PSEPVAHSRRGRLHL CCCCCCCCCCCCCCC | 17.59 | 22496350 | |
410 | Methylation | SEPVAHSRRGRLHLP CCCCCCCCCCCCCCC | 34.89 | 115480575 | |
427 | Phosphorylation | RRSRRAVSVPASFFR CCCCCEEECCHHHHH | 22.77 | 29666759 | |
431 | Phosphorylation | RAVSVPASFFRRLAP CEEECCHHHHHHHCC | 20.88 | 29978859 | |
439 | Phosphorylation | FFRRLAPSPARPRHP HHHHHCCCCCCCCCC | 26.11 | 29666759 | |
442 | Methylation | RLAPSPARPRHPAEA HHCCCCCCCCCCCCC | 31.97 | 115480543 | |
444 | Methylation | APSPARPRHPAEAPN CCCCCCCCCCCCCCC | 42.75 | 115480551 | |
457 | Phosphorylation | PNNGARLSSEVSGSG CCCCCCCCCCCCCCC | 20.92 | 29978859 | |
458 | Phosphorylation | NNGARLSSEVSGSGS CCCCCCCCCCCCCCC | 46.76 | 29978859 | |
461 | Phosphorylation | ARLSSEVSGSGSGNF CCCCCCCCCCCCCCC | 24.16 | 29978859 | |
463 | Phosphorylation | LSSEVSGSGSGNFGE CCCCCCCCCCCCCCC | 23.45 | 29978859 | |
465 | Phosphorylation | SEVSGSGSGNFGEEG CCCCCCCCCCCCCCC | 32.06 | 29978859 | |
477 | Ubiquitination | EEGNPQGKEDQEGSG CCCCCCCCCCCCCCC | 53.52 | - | |
483 | Phosphorylation | GKEDQEGSGGDYMPM CCCCCCCCCCCCCCC | 38.56 | 29978859 | |
487 | Phosphorylation | QEGSGGDYMPMNNWG CCCCCCCCCCCCCCC | 13.34 | 29978859 | |
495 | Phosphorylation | MPMNNWGSGNGRGSG CCCCCCCCCCCCCCC | 22.24 | 26471730 | |
501 | Phosphorylation | GSGNGRGSGGGQGSN CCCCCCCCCCCCCCC | 32.67 | 22496350 | |
517 | Phosphorylation | QGSSSHSSGGNQCSG CCCCCCCCCCCCCCC | 45.34 | - | |
523 | Phosphorylation | SSGGNQCSGEGQGSR CCCCCCCCCCCCCCC | 30.07 | - | |
552 | Phosphorylation | CSRDGQGTAGGHGSG CCCCCCCCCCCCCCC | 17.78 | 29449344 | |
558 | Phosphorylation | GTAGGHGSGGGQRPG CCCCCCCCCCCCCCC | 28.70 | 29449344 | |
570 | Phosphorylation | RPGGGHGSGGGQGPG CCCCCCCCCCCCCCC | 28.70 | 22496350 | |
582 | Phosphorylation | GPGDGHGSGGGKNSG CCCCCCCCCCCCCCC | 28.70 | 26471730 | |
588 | Phosphorylation | GSGGGKNSGGGKGSG CCCCCCCCCCCCCCC | 42.15 | 23312004 | |
594 | Phosphorylation | NSGGGKGSGSGKGSD CCCCCCCCCCCCCCC | 33.02 | 23312004 | |
596 | Phosphorylation | GGGKGSGSGKGSDGD CCCCCCCCCCCCCCC | 38.74 | 23312004 | |
598 | Ubiquitination | GKGSGSGKGSDGDGE CCCCCCCCCCCCCCC | 57.87 | - | |
618 | Ubiquitination | KKRSYFGKLTQSKQQ HHHHHCCCCCCCHHC | 38.16 | 22817900 | |
620 | Phosphorylation | RSYFGKLTQSKQQQM HHHCCCCCCCHHCCC | 33.99 | 29978859 | |
622 | Phosphorylation | YFGKLTQSKQQQMPP HCCCCCCCHHCCCCC | 27.48 | 29978859 | |
623 | Ubiquitination | FGKLTQSKQQQMPPP CCCCCCCHHCCCCCC | 42.16 | 22817900 | |
643 | Phosphorylation | PPPPAGGTGGKGKSG CCCCCCCCCCCCCCC | 41.67 | 26471730 | |
646 | Ubiquitination | PAGGTGGKGKSGGRF CCCCCCCCCCCCCCE | 65.59 | 21890473 | |
656 | Phosphorylation | SGGRFRLYFCVDRGA CCCCEEEEEEEECCC | 7.23 | 30257219 | |
661 | Methylation | RLYFCVDRGATKECK EEEEEEECCCCHHHH | 19.09 | 115480559 | |
671 | Acetylation | TKECKEAKEVKDAEI CHHHHHHHHHCCCCC | 65.22 | 20167786 | |
671 | Ubiquitination | TKECKEAKEVKDAEI CHHHHHHHHHCCCCC | 65.22 | - | |
674 | Ubiquitination | CKEAKEVKDAEIPEG HHHHHHHCCCCCCCH | 52.92 | 32015554 | |
684 | Methylation | EIPEGAARGPHRARA CCCCHHCCCHHHCCC | 59.65 | 115480519 | |
700 | Phosphorylation | DEDEDDPYVPMRPGV CCCCCCCCCCCCCCC | 24.95 | 26356563 | |
709 | Phosphorylation | PMRPGVATPLVSSSD CCCCCCCCCCCCCCC | 18.10 | 29255136 | |
713 | Phosphorylation | GVATPLVSSSDYMPM CCCCCCCCCCCCCCC | 31.63 | 29255136 | |
714 | Phosphorylation | VATPLVSSSDYMPMA CCCCCCCCCCCCCCC | 21.54 | 29255136 | |
715 | Phosphorylation | ATPLVSSSDYMPMAP CCCCCCCCCCCCCCC | 25.84 | 29255136 | |
717 | Phosphorylation | PLVSSSDYMPMAPQN CCCCCCCCCCCCCCC | 12.69 | 29255136 | |
726 | Phosphorylation | PMAPQNVSASKKRHS CCCCCCCCCCCCCCC | 34.08 | 29255136 | |
728 | Phosphorylation | APQNVSASKKRHSRS CCCCCCCCCCCCCCC | 31.07 | 29255136 | |
729 | Ubiquitination | PQNVSASKKRHSRSP CCCCCCCCCCCCCCC | 54.25 | 23503661 | |
730 | Ubiquitination | QNVSASKKRHSRSPF CCCCCCCCCCCCCCC | 53.50 | 23503661 | |
733 | Phosphorylation | SASKKRHSRSPFEDS CCCCCCCCCCCCCCC | 38.19 | 29449344 | |
735 | Phosphorylation | SKKRHSRSPFEDSRG CCCCCCCCCCCCCCC | 36.63 | 29449344 | |
740 | Phosphorylation | SRSPFEDSRGYMMMF CCCCCCCCCCCEEEC | 22.02 | 30257219 | |
741 | Methylation | RSPFEDSRGYMMMFP CCCCCCCCCCEEECC | 53.21 | 115480591 | |
743 | Phosphorylation | PFEDSRGYMMMFPRV CCCCCCCCEEECCCC | 4.82 | 21082442 | |
749 | Methylation | GYMMMFPRVSPPPAP CCEEECCCCCCCCCC | 30.22 | 115480527 | |
751 | Phosphorylation | MMMFPRVSPPPAPSP EEECCCCCCCCCCCC | 32.73 | 29666759 | |
757 | Phosphorylation | VSPPPAPSPPKAPDT CCCCCCCCCCCCCCC | 56.81 | 22496350 | |
764 | Phosphorylation | SPPKAPDTNKEDDSK CCCCCCCCCCCCCCC | 47.32 | 22496350 | |
770 | Phosphorylation | DTNKEDDSKDNDSES CCCCCCCCCCCCCCC | 54.98 | 26126808 | |
775 | Phosphorylation | DDSKDNDSESDYMFM CCCCCCCCCCCCEEE | 45.30 | 29666759 | |
777 | Phosphorylation | SKDNDSESDYMFMAP CCCCCCCCCCEEECC | 37.68 | 22496350 | |
779 | Phosphorylation | DNDSESDYMFMAPGA CCCCCCCCEEECCCC | 11.09 | 22496350 | |
791 | Ubiquitination | PGAGAIPKNPRNPQG CCCCCCCCCCCCCCC | 73.75 | 32015554 | |
803 | Ubiquitination | PQGGSSSKSWSSYFS CCCCCCCCCHHHHCC | 58.87 | 22817900 | |
804 | Phosphorylation | QGGSSSKSWSSYFSL CCCCCCCCHHHHCCC | 33.85 | 26356563 | |
806 | Phosphorylation | GSSSKSWSSYFSLPN CCCCCCHHHHCCCCC | 23.42 | 26356563 | |
807 | Phosphorylation | SSSKSWSSYFSLPNP CCCCCHHHHCCCCCC | 24.76 | 26356563 | |
808 | Phosphorylation | SSKSWSSYFSLPNPF CCCCHHHHCCCCCCC | 7.53 | 26356563 | |
810 | Phosphorylation | KSWSSYFSLPNPFRS CCHHHHCCCCCCCCC | 34.38 | 22496350 | |
817 | Phosphorylation | SLPNPFRSSPLGQND CCCCCCCCCCCCCCC | 36.37 | 26356563 | |
818 | Phosphorylation | LPNPFRSSPLGQNDN CCCCCCCCCCCCCCC | 21.64 | 26356563 | |
826 | Phosphorylation | PLGQNDNSEYVPMLP CCCCCCCCCCCCCCC | 32.92 | 26356563 | |
828 | Phosphorylation | GQNDNSEYVPMLPGK CCCCCCCCCCCCCCC | 15.07 | 22496350 | |
835 | Neddylation | YVPMLPGKFLGRGLD CCCCCCCCCCCCCCC | 35.16 | 32015554 | |
835 | Ubiquitination | YVPMLPGKFLGRGLD CCCCCCCCCCCCCCC | 35.16 | 22817900 | |
839 | Methylation | LPGKFLGRGLDKEVS CCCCCCCCCCCCCCC | 44.65 | 115367455 | |
843 | Ubiquitination | FLGRGLDKEVSYNWD CCCCCCCCCCCCCCC | 66.12 | 21890473 | |
846 | Phosphorylation | RGLDKEVSYNWDPKD CCCCCCCCCCCCHHH | 17.53 | 30257219 | |
847 | Phosphorylation | GLDKEVSYNWDPKDA CCCCCCCCCCCHHHC | 26.00 | 30257219 | |
856 | Phosphorylation | WDPKDAASKPSGEGS CCHHHCCCCCCCCCC | 46.98 | 19413330 | |
859 | Phosphorylation | KDAASKPSGEGSFSK HHCCCCCCCCCCCCC | 53.89 | 22496350 | |
863 | Phosphorylation | SKPSGEGSFSKPGDG CCCCCCCCCCCCCCC | 23.26 | 22496350 | |
865 | Phosphorylation | PSGEGSFSKPGDGGS CCCCCCCCCCCCCCC | 39.37 | 22496350 | |
866 | Ubiquitination | SGEGSFSKPGDGGSP CCCCCCCCCCCCCCC | 51.51 | - | |
872 | Phosphorylation | SKPGDGGSPSKPSDH CCCCCCCCCCCCCCC | 31.37 | 22496350 | |
874 | Phosphorylation | PGDGGSPSKPSDHEP CCCCCCCCCCCCCCC | 59.92 | 22496350 | |
875 | Ubiquitination | GDGGSPSKPSDHEPP CCCCCCCCCCCCCCC | 52.50 | - | |
877 | Phosphorylation | GGSPSKPSDHEPPKN CCCCCCCCCCCCCCC | 56.17 | 22496350 | |
893 | Phosphorylation | AKRPNRLSFITKGYK CCCCCCCEEECCCCC | 16.03 | 29978859 | |
896 | Phosphorylation | PNRLSFITKGYKIKP CCCCEEECCCCCCCC | 19.19 | 29449344 | |
897 | Neddylation | NRLSFITKGYKIKPK CCCEEECCCCCCCCC | 56.26 | 32015554 | |
897 | Ubiquitination | NRLSFITKGYKIKPK CCCEEECCCCCCCCC | 56.26 | 22817900 | |
900 | Ubiquitination | SFITKGYKIKPKPQK EEECCCCCCCCCCCC | 53.58 | 22817900 | |
902 | Ubiquitination | ITKGYKIKPKPQKPT ECCCCCCCCCCCCCC | 42.72 | 22817900 | |
913 | Methylation | QKPTHEQREADSSSD CCCCHHHCCCCCCCC | 37.78 | 115480535 | |
917 | Phosphorylation | HEQREADSSSDYVNM HHHCCCCCCCCCCCC | 38.50 | 29978859 | |
918 | Phosphorylation | EQREADSSSDYVNMD HHCCCCCCCCCCCCC | 27.98 | 26356563 | |
919 | Phosphorylation | QREADSSSDYVNMDF HCCCCCCCCCCCCCC | 36.59 | 26356563 | |
921 | Phosphorylation | EADSSSDYVNMDFTK CCCCCCCCCCCCCCC | 8.82 | 21082442 | |
927 | Phosphorylation | DYVNMDFTKRESNTP CCCCCCCCCCCCCCC | 25.57 | 26356563 | |
928 | Ubiquitination | YVNMDFTKRESNTPA CCCCCCCCCCCCCCC | 54.91 | 22817900 | |
931 | Phosphorylation | MDFTKRESNTPAPST CCCCCCCCCCCCCCC | 50.46 | 22496350 | |
933 | Phosphorylation | FTKRESNTPAPSTQG CCCCCCCCCCCCCCC | 30.06 | 22496350 | |
937 | Phosphorylation | ESNTPAPSTQGLPDS CCCCCCCCCCCCCCC | 35.15 | 22496350 | |
938 | Phosphorylation | SNTPAPSTQGLPDSW CCCCCCCCCCCCCCC | 26.12 | 22496350 | |
952 | Methylation | WGIIAEPRQSAFSNY CCEECCCCCCHHCCC | 34.29 | 115480567 | |
989 | Phosphorylation | IPRANPLSLDSARWP CCCCCCCCCCCCCCC | 31.24 | 26471730 | |
1038 | Phosphorylation | LADSAIRYDAETGRI HHHHHHEEECCCCCE | 17.25 | 22817900 | |
1046 | Phosphorylation | DAETGRIYVVDPFSE ECCCCCEEEECCHHH | 7.96 | 28450419 | |
1052 | Phosphorylation | IYVVDPFSECCMDIS EEEECCHHHCEEEEC | 34.80 | 28450419 | |
1059 | Phosphorylation | SECCMDISLSPSRCS HHCEEEECCCHHHCC | 20.66 | 23607784 | |
1061 | Phosphorylation | CCMDISLSPSRCSEP CEEEECCCHHHCCCC | 17.65 | 28450419 | |
1063 | Phosphorylation | MDISLSPSRCSEPPP EEECCCHHHCCCCCH | 42.41 | 24626860 | |
1089 | Phosphorylation | RRRPQSRSQSFFAAA HHCCCHHHHHHHHHH | 35.11 | 22496350 | |
1091 | Phosphorylation | RPQSRSQSFFAAARA CCCHHHHHHHHHHHH | 24.47 | 29666759 | |
1097 | Methylation | QSFFAAARAAVSAFP HHHHHHHHHHHHCCC | 20.53 | 115480599 | |
1105 | Phosphorylation | AAVSAFPTDSLERDL HHHHCCCCCCCCCCC | 31.59 | 29978859 | |
1107 | Phosphorylation | VSAFPTDSLERDLSP HHCCCCCCCCCCCCC | 34.31 | 19413330 | |
1176 | Methylation | AADAEAVRGAQDVAG HHHHHHHCCCCCCCC | 41.60 | 115480615 | |
1185 | Phosphorylation | AQDVAGGSNPGAHNP CCCCCCCCCCCCCCC | 38.64 | 26471730 | |
1193 | Phosphorylation | NPGAHNPSANLARGD CCCCCCCCCCCCCCC | 34.80 | 26471730 | |
1219 | Phosphorylation | APEPPPRSRRVPRPP CCCCCCCCCCCCCCC | 30.16 | 24173317 | |
1231 | Phosphorylation | RPPEREDSDNDDDTH CCCCCCCCCCCCCCC | 33.29 | 19413330 | |
1237 | Phosphorylation | DSDNDDDTHVRMDFA CCCCCCCCCHHHHHH | 29.30 | 29978859 | |
1252 | Phosphorylation | RRDNQFDSPKRGR-- HHCCCCCCCCCCC-- | 33.34 | 22496350 | |
1254 | Ubiquitination | DNQFDSPKRGR---- CCCCCCCCCCC---- | 72.01 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
859 | S | Phosphorylation | Kinase | CK1G2 | P78368 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IRS4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IRS4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-856; SER-859; SER-865;SER-872; SER-874; SER-877; SER-1107; SER-1231 AND THR-1237, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1038, AND MASSSPECTROMETRY. | |
"Tyrosine phosphoproteomics of fibroblast growth factor signaling: arole for insulin receptor substrate-4."; Hinsby A.M., Olsen J.V., Mann M.; J. Biol. Chem. 279:46438-46447(2004). Cited for: PHOSPHORYLATION AT TYR-921, INTERACTION WITH SHC1; GRB2; PHOSPHOLIPASEC-GAMMA AND PHOSPHATIDYLINOSITOL 3-KINASE, AND MASS SPECTROMETRY. |